Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC17586 Tofacitinib (CP-690550) Citrate

    枸橼酸托法替尼; Tasocitinib citrate; CP-690550 citrate

    A pan-JAK inhibitor
  3. GC15295 AUY922 (NVP-AUY922)

    VER-52296, AUY-922, AUY 922, Luminespib

    AUY922 (NVP-AUY922)是一种高效且选择性的 HSP90抑制剂,对 HSP90α和 HSP90β的 IC50 值分别为 13nM和 21nM。
  4. GC11720 17-AAG (KOS953)

    坦螺旋霉素; 17-AAG; NSC 330507; CP 127374

    17-AAG(格尔德霉素)是一种天然的苯醌安沙霉素抗生素,是第一个确定的 Hsp90 抑制剂。
  5. GC18008 PCI-34051

    N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺,PCI34051, PCI 34051

    PCI-34051是一种高效且选择性的HDAC8抑制剂,其IC50为10nM。
  6. GC13055 Mocetinostat (MGCD0103, MG0103)

    N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺,MGCD-0103

    An orally available HDAC inhibitor
  7. GC14998 Rocilinostat (ACY-1215)

    Ricolinostat

    A selective inhibitor of HDAC6
  8. GC12191 LY-411575

    (AS)-N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羟基苯乙酰胺

    A γ-secretase inhibitor
  9. GC14209 Apoptosis Activator 2

    1-(3,4-二氯苄基)-1H-吲哚-2,3-二酮

    An activator of caspases
  10. GC10801 Disulfiram

    双硫仑; Tetraethylthiuram disulfide; TETD

    An irreversible inhibitor of aldehyde dehydrogenase
  11. GC10510 LDN 57444

    Ubiquitin C-terminal Hydrolase L1 Inhibitor, UCHL1 Inhibitor

    LDN 57444是一种小分子抑制剂,可阻断UCHL1的去泛素化酶活性(Ki=0.40μM;IC50=0.88μM),抑制UCHL3的IC50值为25μM。
  12. GC13508 Trametinib (GSK1120212)

    曲美替尼; GSK1120212; JTP-74057

    Trametinib (GSK1120212, JTP-74057) 是第二代 MEK 激酶小分子抑制剂。
  13. GC15568 Dasatinib (BMS-354825)

    达沙替尼; BMS-354825

    Dasatinib (BMS-354825)是一种高效、口服生物利用度高的多靶点酪氨酸激酶抑制剂,对BCR-ABL、SRC家族激酶、c-KIT和PDGFR-β的IC₅₀分别为0.4nM、0.5nM、100nM和180nM。
  14. GC11931 BKM120

    BKM-120,Buparlisib,BKM 120,NVP-BKM120,NVP-BKM-120

    An inhibitor of class I PI3K isoforms
  15. GC10397 PD0325901

    N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺,PD0325901,PD-0325901,PD 0325901,PD325901,PD 325901,PD-325901

    PD0325901是一种具口服活性、选择性和非ATP竞争性的丝裂原活化蛋白激酶激酶(MEK)抑制剂,IC50值为0.33nM。
  16. GC17369 Sorafenib

    索拉非尼; Bay 43-9006

    索拉非尼Sorafenib是Raf-1和B-Raf的多激酶抑制剂,IC50分别为6 nM和22 nM;Sorafenib对VEGFR-2 VEGFR-3 PDGFR-β Flt-3和c-KIT也有抑制作用,IC50值分别为90 nM、20 nM、57 nM、59 nM和68 nM;索拉非尼能诱导自噬细胞凋亡和激活铁死亡,并具有抗肿瘤活性。
  17. GC10512 Y-27632 dihydrochloride

    y-27632, Y27632, Y-27632 dihydrochloride, Y 27632

    Y-27632 dihydrochloride 作为一种选择性 Rho 激酶抑制剂,是一种新型支气管扩张剂。
  18. GC12405 ABT-263 (Navitoclax)

    Navitoclax,ABT-263,ABT263,ABT 263

    ABT-263 (Navitoclax) 是 Bcl-xL、Bcl-2 和 Bcl-w 的抑制剂,Ki 分别≤0.5 nM、≤1 nM 和≤1 nM。
  19. GC12942 DAPT (GSI-IX)

    gamma-Secretase Inhibitor IX, DAPT, GSI-IX

    DAPT (GSI-IX) 是一种具有口服活性的 γ-分泌酶抑制剂,对人原代神经元培养物中产生的总淀粉样蛋白-β (Aβ) 和 Aβ42 的 IC50 分别为 115 nM 和 200 nM。
  20. GC17234 ABT-737

    ABT 737, ABT737

    ABT-737作为一种BH3模拟药物,是Bcl-2家族的抑制剂,可抑制Bcl2、Bcl-xL和Bcl-w的活性,IC50值<1nM。
  21. GC14069 ABT-199

    维奈妥拉; ABT-199; GDC-0199; Venetoclax

    Venetoclax (ABT-199, GDC-0199) 是 Bcl-2 的选择性抑制剂,在无细胞试验中 K i 为 0.01 nM。
  22. GN10122 Linalool

    芳樟醇

    A monoterpene alcohol with diverse biological activities
  23. GN10751 Dictamnine

    白鲜碱; Dictamnine; Dectamine

    An alkaloid with diverse biological activities
  24. GN10801 Senkyunolide I

    洋川芎内酯I

    Senkyunolide I 是从川芎中分离出来的,是一种抗偏头痛化合物。
  25. GN10280 Sinensetin

    5,6,7,3',4'-五甲氧基黄酮,Pedalitin permethyl ether

    An anti-inflammatory flavone
  26. GN10506 Umbelliferone

    7-羟基香豆素; 7-Hydroxycoumarin; Hydrangin; NSC 19790

    A derivative and metabolite of coumarin with diverse biological activities
  27. GN10456 L-Theanine

    L-茶氨酸; L-Glutamic Acid γ-ethyl amide; Nγ-Ethyl-L-glutamine

    A neuroprotective amino acid
  28. GN10113 Cepharanthine

    千金藤碱

    Cepharanthine是一种双苄基异喹啉生物碱,具有强效抗病毒活性,对SARS-CoV-2和HIV-1的EC50值分别为0.15µM和0.026µM。
  29. GN10358 Berbamine hydrochloride

    盐酸小檗胺

    A bisbenzylisoquinoline alkaloid with diverse biological activities
  30. GN10213 Sinomenine Hydrochloride

    盐酸青藤碱; Cucoline hydrochloride

    Sinomenine Hydrochloride是NF-κB活化的抑制剂。
  31. GN10666 Isoalantolactone

    异土木香内酯; (+)-Isoalantolactone; Isohelenin

    A sesquiterpene lactone with diverse biological activities
  32. GN10030 Fisetin

    漆黄素

    Fisetin是一种天然黄酮醇,存在于许多水果和蔬菜中,具有多种生物活性。
  33. GN10503 Piceatannol

    白皮杉醇; Astringenin; trans-Piceatannol

    Piceatannol(3,3 ',4,5 ' -反式三羟基二苯乙烯)是天然存在的白藜芦醇羟基化类似物。
  34. GN10216 Shikonin

    紫草素; C.I. 75535; Isoarnebin 4

    Shikonin是一种含醌的天然产物。Shikonin是一种有效的TMEM16A氯离子通道抑制剂,IC50为6.5μM。
  35. GN10797 Tangeretin

    桔皮素; Tangeritin; NSC53909; NSC618905

    Tangeretin是一种从柑橘皮中提取的天然多甲氧基黄酮化合物,是Notch-1的抑制剂。
  36. GN10254 Ginsenoside Rc

    人参皂苷 Rc; Panaxoside Rc

    A saponin with diverse biological activities
  37. GN10629 5,7-dihydroxychromone

    5,7-二羟基色酮

    5,7-dihydroxychromone是一种从花生壳中提取的黄酮类分解产物,能抑制曼陀罗、玉米、花生和小麦胚根的伸长。
  38. GN10269 Wedelolactone

    蟛蜞菊内酯

    A natural NF-κB inhibitor
  39. GN10741 Garcinone D

    伽升沃 D

    A xanthone with diverse biological activities
  40. GN10504 Echinocystic acid

    刺囊酸

    A triterpene with diverse biological activities
  41. GN10082 Gossypol

    棉酚; BL 193

    Gossypol是一种从棉花植株中提取的脂溶性多酚类化合物,具有抗生育、抗氧化和抗癌特性。
  42. GN10341 Acetate gossypol

    醋酸棉酚; (±)-Gossypol-acetic acid; BL-193 (acetic acid)

    Acetate gossypol是一种从棉花植株中提取的脂溶性多酚类化合物,具有抗生育、抗氧化和抗癌特性。
  43. GN10318 Danshensu

    丹参素

    A salvianolic acid with diverse biological activities
  44. GN10361 Pseudolaric Acid B

    土荆皮乙酸

    Compound from Chinese traditional medicine with reported antifungal, anticancer actions
  45. GN10543 caudatin

    告达亭苷元

    A C-21 steroid with anticancer activity
  46. GN10035 9-Methoxycamptothecin

    10-甲氧基喜树碱

    9-Methoxycamptothecin (MCPT) 分离自 Nothapodytes foetida,通过抑制拓扑异构酶具有抗肿瘤活性。 9-Methoxycamptothecin (MCPT) 在癌症中诱导强烈的 G2/M 期阻滞和细胞凋亡。
  47. GN10507 Baohuoside I

    宝藿苷 I; Icariin-II; Icariside-II

    宝活苷 I 是一种从淫羊藿中分离出来的黄酮类化合物,可作为 CXCR4 抑制剂,下调 CXCR4 表达,诱导细胞凋亡并具有抗肿瘤活性。
  48. GN10123 Columbianadin

    二氢欧山芹醇当归酸酯

    A coumarin with diverse biological activities
  49. GN10005 Schisandrin C

    五味子丙素; Schizandrin-C; Wuweizisu-C

    A lignan with diverse biological activities
  50. GN10484 Amentoflavone

    穗花杉双黄酮; Didemethyl-ginkgetin

    A biflavonoid with diverse biological activities
  51. GN10733 Carnosic acid

    鼠尾草酸

    An antioxidant

Items 2551 to 2600 of 2721 total

per page

Set Descending Direction